Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001088242 | SCV000252807 | benign | Long QT syndrome | 2024-01-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000243061 | SCV000319052 | likely benign | Cardiovascular phenotype | 2016-02-17 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV000198485 | SCV001155129 | likely benign | not provided | 2023-08-01 | criteria provided, single submitter | clinical testing | AKAP9: BP4, BP7 |
ARUP Laboratories, |
RCV001000128 | SCV001156571 | likely benign | Long QT syndrome 11 | 2019-08-09 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000198485 | SCV001870810 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001000128 | SCV002524877 | benign | Long QT syndrome 11 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001699001 | SCV005040460 | benign | not specified | 2024-03-03 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001699001 | SCV001922367 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001699001 | SCV001954986 | benign | not specified | no assertion criteria provided | clinical testing |